- Home
- ONFO vs QNRX Comparison
ONFO vs QNRX Comparison
Compare ONFO & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONFO
- QNRX
- Stock Information
- Founded
- ONFO 2018
- QNRX 2018
- Country
- ONFO United States
- QNRX United States
- Employees
- ONFO N/A
- QNRX N/A
- Industry
- ONFO Computer Software: Programming Data Processing
- QNRX Medical/Dental Instruments
- Sector
- ONFO Technology
- QNRX Health Care
- Exchange
- ONFO Nasdaq
- QNRX Nasdaq
- Market Cap
- ONFO 5.0M
- QNRX 4.8M
- IPO Year
- ONFO 2022
- QNRX N/A
- Fundamental
- Price
- ONFO $1.03
- QNRX $13.44
- Analyst Decision
- ONFO
- QNRX
- Analyst Count
- ONFO 0
- QNRX 0
- Target Price
- ONFO N/A
- QNRX N/A
- AVG Volume (30 Days)
- ONFO 92.1K
- QNRX 831.2K
- Earning Date
- ONFO 11-14-2025
- QNRX 11-07-2025
- Dividend Yield
- ONFO N/A
- QNRX N/A
- EPS Growth
- ONFO N/A
- QNRX N/A
- EPS
- ONFO N/A
- QNRX N/A
- Revenue
- ONFO $10,508,728.00
- QNRX N/A
- Revenue This Year
- ONFO N/A
- QNRX N/A
- Revenue Next Year
- ONFO N/A
- QNRX N/A
- P/E Ratio
- ONFO N/A
- QNRX N/A
- Revenue Growth
- ONFO 78.36
- QNRX N/A
- 52 Week Low
- ONFO $0.61
- QNRX $5.01
- 52 Week High
- ONFO $1.95
- QNRX $48.30
- Technical
- Relative Strength Index (RSI)
- ONFO 44.46
- QNRX 55.52
- Support Level
- ONFO $1.00
- QNRX $12.00
- Resistance Level
- ONFO $1.10
- QNRX $17.84
- Average True Range (ATR)
- ONFO 0.08
- QNRX 4.51
- MACD
- ONFO -0.01
- QNRX 0.13
- Stochastic Oscillator
- ONFO 10.00
- QNRX 18.06
About ONFO Onfolio Holdings Inc.
Onfolio Holdings Inc actively manages small online businesses that operate in sectors with long-term growth opportunities, have positive and stable cash flows, face minimal threats of technological or competitive obsolescence, and can be managed by existing teams or have management teams largely in place. The company operates in two business segments: Business to Business (B2B) and Business to Consumers (B2C). The majority of its revenue is generated from the Business-to-Business (B2B) segment, which includes the results of operations of Eastern Standard, RevenueZen, DDS Rank, SEO Butler, Contentellect, DealPipe, and Onfolio LLC.
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.